These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An insight into pleiotropic regulators Agr and Sar: molecular probes paving the new way for antivirulent therapy. Arya R; Princy SA Future Microbiol; 2013 Oct; 8(10):1339-53. PubMed ID: 24059923 [TBL] [Abstract][Full Text] [Related]
5. Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective. Gordon CP; Williams P; Chan WC J Med Chem; 2013 Feb; 56(4):1389-404. PubMed ID: 23294220 [TBL] [Abstract][Full Text] [Related]
6. Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against Gao P; Davies J; Kao RYT mBio; 2017 Sep; 8(5):. PubMed ID: 28874472 [No Abstract] [Full Text] [Related]
7. Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues. Arciola CR; Visai L; Testoni F; Arciola S; Campoccia D; Speziale P; Montanaro L Int J Artif Organs; 2011 Sep; 34(9):771-80. PubMed ID: 22094556 [TBL] [Abstract][Full Text] [Related]
8. The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus. Yeo WS; Arya R; Kim KK; Jeong H; Cho KH; Bae T Sci Rep; 2018 Feb; 8(1):2521. PubMed ID: 29410445 [TBL] [Abstract][Full Text] [Related]
9. Suppression of Gao P; Ho PL; Yan B; Sze KH; Davies J; Kao RYT Proc Natl Acad Sci U S A; 2018 Jul; 115(31):8003-8008. PubMed ID: 30012613 [TBL] [Abstract][Full Text] [Related]
10. The lysine-peptoid hybrid LP5 maintain activity under physiological conditions and affects virulence gene expression in Staphylococcus aureus. Gottschalk S; Ingmer H; Thomsen LE Peptides; 2016 Apr; 78():24-9. PubMed ID: 26851701 [TBL] [Abstract][Full Text] [Related]
13. Structurally refined beta-lactones as potent inhibitors of devastating bacterial virulence factors. Böttcher T; Sieber SA Chembiochem; 2009 Mar; 10(4):663-6. PubMed ID: 19206121 [TBL] [Abstract][Full Text] [Related]
14. Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics. Badarau A; Trstenjak N; Nagy E Adv Exp Med Biol; 2017; 966():15-35. PubMed ID: 28455832 [TBL] [Abstract][Full Text] [Related]
15. Targeting MgrA-mediated virulence regulation in Staphylococcus aureus. Sun F; Zhou L; Zhao BC; Deng X; Cho H; Yi C; Jian X; Song CX; Luan CH; Bae T; Li Z; He C Chem Biol; 2011 Aug; 18(8):1032-41. PubMed ID: 21867918 [TBL] [Abstract][Full Text] [Related]
16. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Liu CI; Liu GY; Song Y; Yin F; Hensler ME; Jeng WY; Nizet V; Wang AH; Oldfield E Science; 2008 Mar; 319(5868):1391-4. PubMed ID: 18276850 [TBL] [Abstract][Full Text] [Related]
17. FtsZ inhibition: a promising approach for antistaphylococcal therapy. Singh P; Panda D Drug News Perspect; 2010 Jun; 23(5):295-304. PubMed ID: 20603653 [TBL] [Abstract][Full Text] [Related]
18. Perturbation of Staphylococcus aureus gene expression by the enoyl-acyl carrier protein reductase inhibitor AFN-1252. Parsons JB; Kukula M; Jackson P; Pulse M; Simecka JW; Valtierra D; Weiss WJ; Kaplan N; Rock CO Antimicrob Agents Chemother; 2013 May; 57(5):2182-90. PubMed ID: 23459481 [TBL] [Abstract][Full Text] [Related]
19. Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence. Chen F; Di H; Wang Y; Cao Q; Xu B; Zhang X; Yang N; Liu G; Yang CG; Xu Y; Jiang H; Lian F; Zhang N; Li J; Lan L Nat Chem Biol; 2016 Mar; 12(3):174-9. PubMed ID: 26780405 [TBL] [Abstract][Full Text] [Related]
20. Phloretin reduces cell injury and inflammation mediated by Staphylococcus aureus via targeting sortase B and the molecular mechanism. Wang G; Gao Y; Wang H; Wang J; Niu X Appl Microbiol Biotechnol; 2018 Dec; 102(24):10665-10674. PubMed ID: 30310962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]